How Long for UZEDY to Reach Steady State?
UZEDY (risperidone) extended-release injectable suspension reaches steady-state plasma concentrations after 4 weekly 50 mg doses or after 2 monthly 100 mg doses or 1 quarterly 200 mg dose.[1][2]
What Steady State Means for UZEDY
Steady state occurs when drug levels stabilize, with plasma concentrations fluctuating predictably within a dosing interval. For UZEDY's subcutaneous microspheres, this happens due to gradual risperidone release, typically measured by consistent risperidone plus active metabolite (9-hydroxyrisperidone) levels.[1]
Dosing Schedules and Time to Steady State
- Weekly (50 mg): Steady state after 4 doses (about 4 weeks).[1][2]
- Monthly (100 mg): Steady state after 2 doses (about 2 months).[1][2]
- Quarterly (200 mg): Steady state after 1 dose (about 3 months).[1][2]
These timelines come from pharmacokinetics in patients with schizophrenia, assuming subcutaneous administration without loading doses.[1]
Factors Affecting Time to Steady State
Half-life of risperidone plus metabolite ranges 5-16 days, extended by the microsphere formulation. No food effect or major impact from mild liver/kidney impairment, but dose adjustments apply for severe cases or CYP2D6 poor metabolizers.[1][3] Steady state supports once-monthly or quarterly maintenance after initial titration.
Comparison to Other Long-Acting Risperidone Injectables
| Formulation | Time to Steady State | Dosing Frequency |
|-------------|----------------------|------------------|
| UZEDY | 4 weeks (weekly), 2 months (monthly), 3 months (quarterly) | Weekly/monthly/quarterly |
| Risperdal Consta | 4-6 weeks (with oral supplementation) | Every 2 weeks |
| Perseris | 4 weeks | Monthly |
UZEDY allows flexible initiation without oral overlap, unlike Risperdal Consta.[1][4]
Patient Considerations During Build-Up
Therapeutic effects may start before steady state, but full efficacy aligns with stabilization. Monitor for injection-site reactions or extrapyramidal symptoms early.[1][3] Switching from other antipsychotics requires gradual transition per label.
[1]: UZEDY Prescribing Information
[2]: FDA Label for UZEDY
[3]: Drugs.com - UZEDY Pharmacokinetics
[4]: Risperdal Consta PI